Plain-English translation of NCT06439524 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Endometriosis research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
United States
Phase
Large-scale testing
Sponsor
Main Line Health
Collaborators
Pfizer, Sumitomo Pharma Switzerland GmbH
Enrollment target
~110 participants
Started
August 2024
Primary completion
June 2028
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jordan Klebanoff, MD
Main Line Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.